PDGF gene therapy enhances expression of VEGF and bFGF genes.
Machens
Hans-Günther
HG
Niedworok
Christian
C
Spanholtz
Timo
T
Maichle
Alexandra
A
D000818:Animals; D000077214:Becaplermin; D002470:Cell Survival; D002478:Cells, Cultured / Q000378:metabolism; D018076:DNA, Complementary / Q000008:administration & dosage / Q000627:therapeutic use; D016222:Fibroblast Growth Factor 2 / Q000096:biosynthesis* / Q000235:genetics; D005347:Fibroblasts / Q000166:cytology; D005786:Gene Expression Regulation; D015316:Genetic Therapy; D010982:Platelet-Derived Growth Factor / Q000235:genetics / Q000502:physiology*; D020574:Proto-Oncogene Proteins c-sis; D051381:Rats; D011993:Recombinant Fusion Proteins / Q000502:physiology; D013524:Surgical Flaps; D042461:Vascular Endothelial Growth Factor A / Q000096:biosynthesis* / Q000235:genetics
D018076:DNA, Complementary; D010982:Platelet-Derived Growth Factor; D020574:Proto-Oncogene Proteins c-sis; D011993:Recombinant Fusion Proteins; D042461:Vascular Endothelial Growth Factor A; C467498:vascular endothelial growth factor A, rat; D016222:Fibroblast Growth Factor 2; D000077214:Becaplermin